About: Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Luigi Gugliotta et al published December 2011 in Leukemia Research

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2011 (uk) im Dezember 2011 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Luigi Gugliotta et al published December 2011 in Leukemia Research (en)
publication date	wds:Q56983751-7174D239-53EC-4E7A-A2F0-39E04F698616
publication date	2011-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56983751-7DDFE411-9980-472E-ADCD-ABD8FF02E0E0
language of work or name	English
author name string	wds:Q56983751-00F8C456-0E20-451E-A83D-44A5D575165B wds:Q56983751-01DF9CFE-7AC4-4387-A968-D4DE5F679CE9 wds:Q56983751-03C8315B-E374-4EA8-980F-C06F5E2513C9 wds:Q56983751-129513F4-B1B4-4AE6-8AF0-6B1BE1E36D5E wds:Q56983751-1B69F0B9-A7D5-4955-8D2D-CBF0FEC03CAF wds:Q56983751-26E31353-F99F-4E4E-95FD-146004B136A8 wds:Q56983751-41310C00-93B3-4AF2-BA16-7131718342C7 wds:Q56983751-528F967F-D78F-4ECE-BEFA-BFCE69570777 wds:Q56983751-5EC58F92-7937-49FD-8902-4BC431042377 wds:Q56983751-6798A51B-57A6-46AD-A3C1-0BAE7D077A5F wds:Q56983751-67D8DBB3-29C8-44FD-B1A3-7A2C0014D6CF wds:Q56983751-6DBA0E35-31A6-4107-BC97-ABADA1FE8278 wds:Q56983751-AA6BE5C3-0738-471A-AEF6-0DA186F854CF wds:Q56983751-AAD57D6D-F7B0-47C0-9C51-3163B0B4377F wds:Q56983751-B3BD04F2-B5C1-4209-9E03-DC4D62146841 wds:Q56983751-CD3638D2-3E9C-439A-AA85-2CEA8BFDC8EE wds:Q56983751-F470B0F6-EF68-4BC5-9C24-FA111E2A9FDE wds:Q56983751-F7BD9AC4-D740-47E4-95BD-4820584E8226 wds:Q56983751-FF2C1844-B2C7-4F07-AFB9-BC4AD20D62E5
author name string	Alessandro M Vannucchi Alberto Grossi Anna Candoni Nicola Vianelli Luigi Gugliotta Anna Marina Liberati Alessandra Iurlo Emilio Usala Ivana Pierri Monica Crugnola Maria Gabriella Mazzucconi Alessia Tieghi Emma Cacciola Rossella Cacciola Potito Rosario Scalzulli Monia Lunghi Katia Codeluppi Giovanni Tortorella Fausto Palmieri
rdfs:label	Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (en) Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (nl)
skos:prefLabel	Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (en) Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (nl)
name	Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (en) Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (nl)
author	wds:Q56983751-4A60A7FA-3CA2-4013-8BF4-30BFAA514ACD wds:Q56983751-799D169A-EBEF-4B31-8694-DCC1750A74A6 wds:Q56983751-811F9926-3C91-4C7B-B66C-CB75E9715645
author	Giorgina Specchia Rosanna Ciancia Vincenzo Martinelli
title	wds:Q56983751-E6D9C5CB-8EB2-4A17-A6CE-0B81BFBD9FF7
title	Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia (en)
page(s)	wds:Q56983751-BB571149-A3CB-4659-BDBB-C3ACBB035CB0
page(s)	1557-63
instance of	wds:Q56983751-A7A44268-3EFE-4C21-AFD0-5B7E60A0AD04
instance of	scholarly article
main subject	wds:Q56983751-E0AA6FEF-A45A-42DD-85BA-BAE93C65FB19
main subject	blood circulation
PubMed ID	wds:Q56983751-7E5B8C71-285A-46D5-AE56-B8FECF911467
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21764130
PubMed ID	21764130
published in	wds:Q56983751-6B3A5249-9604-4C7E-AE0D-1843D082ED94
published in	Leukemia Research
issue	wds:Q56983751-AA027D2E-AD8E-4D88-8A61-B52E2F825715
volume	wds:Q56983751-E3CB24EA-0FB7-4C13-BFC6-7F6502AAB750
issue	12
volume	35
DOI	wds:Q56983751-681CB0F9-02E4-4395-A40E-521722440D99
DOI	http://dx.doi.org/10.1016/J.LEUKRES.2011.06.030
DOI	10.1016/J.LEUKRES.2011.06.030
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56983751
is cites work of	Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial Pharmacological management of essential thrombocythemia Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS study Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.
is cites work of	wds:Q36650197-E92262D5-E1F6-468B-8734-55E2ABF00DD9 wds:Q28074777-1BD77EE2-42CA-42BF-A54F-E6A75655E7E3 wds:Q36666769-7C2B8DB7-9CB5-42EA-A823-C3A3FB1BEF61 wds:Q34344384-8A38EAA8-6AF3-433D-B18D-7310A7684254 wds:Q39563439-0C6EF66D-A6FE-44A3-94BB-A8C04DAA9FE8 wds:Q38586505-A1706161-CD61-49FD-BDCF-449183DA7396

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software